Skip to content
Dawson James Logo
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • Customer Account Agreement
    • MSRB
    • IRA Contributions for 2024
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2023 CONFERENCE
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
  • ABOUT US
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • LOCATIONS
    • CAREERS
  • REG BI/CRS
  • DISCLOSURES
    • Customer Account Agreement
    • MSRB
    • IRA Contributions for 2024
  • SERVICES
    • INDIVIDUAL INVESTORS
    • INVESTMENT BANKING
    • RESEARCH
    • CAPITAL MARKETS
    • SYNDICATE
    • INSTITUTIONAL SALES & TRADING
    • INSURANCE
    • WEALTH MANAGEMENT
  • TRANSACTIONS
  • CAREERS
  • RESEARCH
  • CONFERENCES
    • 2023 CONFERENCE
    • 2022 CONFERENCE
    • 2021 CONFERENCE
    • 2019 CONFERENCE
    • 2018 CONFERENCE
    • 2017 CONFERENCE
    • Uplist BootCamp 2017
    • 2016 CONFERENCE
    • 2015 CONFERENCE
  • NEWS
  • CONTACT US
Loading...
Report – CTXRnerdadmin2024-04-01T11:44:34-04:00

Citius Pharmaceuticals Inc.

Latest Publication

Termination Report 04/01/24
Update Report 02/15/2024
Update Report 02/14/2024
Update Report 01/31/2024
Update Report 01/11/2024
Update Report 01/02/2024
Update Report 11/02/2023
Update Report 10/24/2023
Update Report 09/11/2023
Company Update 08/15/2023
Company Update 07/31/2023
Company Update 06/21/2023
Company Update 05/18/2023
Price Target Change 05/04/2023
Company Update 04/25/2023
Company Update 03/31/2023
Company Update 02/14/2023
Company Update 12/23/2022
Company Update 12/06/2022
Company Update 09/28/2022
Company Update 08/15/2022
Company Update 07/12/2022
Company Update 05/25/2022
Company Update 05/13/2022
Company Update 05/05/2022
Company Update 04/26/2022
Company Update 04/18/2022
Company Update 04/06/2022
Company Update 02/15/2022
Company Update 02/11/2022
Company Update 12/06/2021
Price Target Change 09/09/2021
Company Update 07/01/2021
Company Update 06/09/2021
Company Update 05/21/2021
Company Update 03/10/2021
Company Update 02/18/2021
Company Update 1/26/2021
Company Update 11/30/2020
Company Update 09/29/2020
Company Update 09/28/2020
Company Update 05/26/2020
Company Update 02/25/2020
Company Update 02/04/2020
Company Update 12/19/19
Company Update 10/7/19
Company Update 9/6/19
Company Update 7/6/18
Initiation 12/15/17

  • Reports
  • Sector Research


“To view Dawson James’ Business Continuity Plan please click here for more information.”

Please note our Corporate address has changed as of October 12, 2020.

Dawson James Securities Inc.
Member FINRA/SIPC
101 N. Federal Highway Suite 600 Boca Raton, Florida 33432
Privacy Pledge | Contact Us | Terms & Conditions | FINRA | SIPC | FINRA BrokerCheck | Fees | Disclosures | Rule 606 Reports | Client Login
Page load link
Go to Top